Creating the future of
precision medicine on cancer treatment

We are the first Chinese precision medicine company which introduced NGS testing panels for comprehensive genomic profiling. We are devoted to providing the most high quality comprehensive molecular diagnostic technology to assist in personalized treatments for patients and physicians.

We work together with physicians to explore advanced cancer treatment options in precision medicine, as well as innovations on researches and clinical trials on real world studies.

Our laboratory is CLIA certified and CAP accredited. It is also certified as China third-party medical laboratory. We are equipped with multiple international standardized high quality sequencing laboratories. Our laboratories have achieved full marks consecutively on both national and international quality assessments.

Based on real-world studies
High-quality scientific research papers


SCI impact factor


Proven tracks
More than 50 solid cancers




Scientific research

CAP Accreditation
CLIA Certification
By the Centers for Medicare
& Medicaid Services
Cancer Moonshot SM
of the United States
Chinese Research Center
of International Cancer
Proteogenome Consortium
Co-founded a cancer
genomic information database
of Chinese patients with
the Chinese Society
of Clinical Oncology and
the Eastern Clinical Center
of Oncology
Built a new clinical
trial sharing platform
with CTONG